Stat1-positive and Stat1-negative RT2-cancers expressed PD-L1 in the tumour tissue and on more than 10% of the isolated cancer cells (Supplementary Fig. 4a, b), showing that Stat1-negative RT2-cancers expressed the target of the anti-PD-L1 mAb. This evidence concerns the gene STAT1 and neoplasm.